Mimetas Us, Inc.

MIMETAS develops organ-on-a-chip technology platforms, including its OrganoPlate® system, that create advanced human tissue and disease models for pharmaceutical drug discovery and development. The company provides these models and related services to pharmaceutical companies to accelerate drug testing, reduce development risks, and improve the prediction of how drugs will function in humans.